导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 6.91% | 948/4773 |
| 近一周 | -2.48% | 2311/5462 |
| 近一月 | -10.29% | 5019/5421 |
| 近一季 | 18.88% | 68/5209 |
| 近半年 | 8.62% | 571/4920 |
| 近一年 | -9.98% | 3373/4366 |
| 近两年 | 58.15% | 1262/2954 |
| 近三年 | 12.49% | 1686/2253 |
| 成立以来 | -8.88% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
0.99% 1393/4961 |
0.72% 3141/5312 |
- - |
- - |
| 2025 | 27.44% 1556/4813 |
15.32% 178/3635 |
3.59% 982/4076 |
23.22% 1562/4524 |
-13.43% 4304/4813 |
| 2024 | -17.00% 2512/3463 |
-15.28% 2541/2808 |
-13.11% 2624/3014 |
23.45% 399/3129 |
-8.67% 2875/3463 |
| 2023 | -14.81% 1622/2656 |
0.82% 1691/2280 |
-13.41% 2210/2385 |
1.38% 314/2515 |
-3.74% 777/2655 |
| 2022 | -28.51% 1564/2207 |
-9.42% 327/1919 |
-7.53% 1892/2016 |
-20.98% 1891/2113 |
8.01% 276/2208 |
| 2021 | -16.22% 1164/1822 |
-2.80% 705/1255 |
12.22% 341/1330 |
-17.26% 1409/1466 |
-7.17% 1564/1822 |
| 2020 | 66.33% 89/1250 |
10.50% 19/1028 |
36.72% 16/1067 |
6.19% 867/1164 |
3.68% 896/1184 |
| 2019 | 55.76% 70/1092 |
33.73% 132/754 |
-5.42% 469/804 |
13.26% 26/850 |
8.73% 294/918 |
| 2018 | -30.27% 467/834 |
- - |
- - |
- - |
-17.45% 650/691 |
| 2017 | -5.55% 511/714 |
- - |
- - |
- - |
- - |
| 2016 | - - |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 汇添富中证精准医疗指数(LOF)C VS. 长安沪深300非周期A(740101) |